resiquimod has been researched along with mannans in 3 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (mannans) | Trials (mannans) | Recent Studies (post-2010) (mannans) |
---|---|---|---|---|---|
465 | 14 | 318 | 6,405 | 407 | 2,903 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Caisová, V; Chmelař, J; Glaserová, S; Husníková, H; Jochmanová, I; Kopecký, J; Krejčová, G; Kumžáková, Z; Paďouková, L; Vácová, N; Vieru, A; Wolf, KI; Ženka, J | 1 |
Caisová, V; Chmelař, J; Jochmanová, I; Kopecký, J; Krejčová, G; Kvardová, K; Masáková, K; Nedbalová, P; Paďouková, L; Uher, O; Ženka, J | 1 |
Caisova, V; Chlastakova, A; Chmelar, J; Frejlachova, A; Hansen, P; Kopecky, J; Kvardova, K; Lencova, R; Masakova, K; Pacak, K; Padoukova, L; Skalickova, M; Uher, O; Venhauerova, A; Zenka, J; Zhuang, Z | 1 |
3 other study(ies) available for resiquimod and mannans
Article | Year |
---|---|
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Imidazoles; Immunity, Innate; Immunotherapy; Ligands; Mannans; Melanoma, Experimental; Mice; Neoplasms; Neutrophil Infiltration; Neutrophils; Phagocytosis; Poly I-C; Respiratory Burst; Toll-Like Receptors | 2016 |
Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Imidazoles; Immunotherapy; Lipopolysaccharides; Lymphocytes, Tumor-Infiltrating; Mannans; Melanoma, Experimental; Mice, Inbred C57BL; Neutrophils; Pancreatic Neoplasms; Phagocytosis; Poly I-C; Teichoic Acids; Toll-Like Receptors; Tumor Burden | 2018 |
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; CD40 Antigens; Imidazoles; Immunotherapy; Ligands; Lipopolysaccharides; Mannans; Mice; Pancreatic Neoplasms; Poly I-C; T-Lymphocytes; Teichoic Acids; Toll-Like Receptors | 2021 |